PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 165 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2015. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $826,000 | +24.8% | 26,921 | +218.8% | 0.02% | +185.7% |
| Q4 2015 | $662,000 | +21.5% | 8,445 | +16.8% | 0.01% | +40.0% |
| Q3 2015 | $545,000 | -65.5% | 7,230 | -46.5% | 0.01% | -66.7% |
| Q2 2015 | $1,578,000 | +397.8% | 13,518 | +908.8% | 0.02% | +275.0% |
| Q1 2015 | $317,000 | -79.8% | 1,340 | -83.9% | 0.00% | -55.6% |
| Q4 2014 | $1,572,000 | +238.1% | 8,303 | +18.0% | 0.01% | +350.0% |
| Q2 2014 | $465,000 | – | 7,036 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 207,500 | $21,609,000 | 4.97% |
| WEATHERBIE CAPITAL, LLC | 250,296 | $26,066,000 | 2.47% |
| Redmile Group, LLC | 172,092 | $17,922,000 | 2.14% |
| Tekla Capital Management LLC | 185,820 | $19,351,000 | 1.93% |
| Iguana Healthcare Management, LLC | 35,000 | $3,645,000 | 1.68% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $592,210,000 | 1.62% |
| Atika Capital Management LLC | 11,350 | $1,182,000 | 1.01% |
| Eventide Asset Management | 44,900 | $4,676,000 | 0.73% |
| Ghost Tree Capital, LLC | 11,330 | $1,180,000 | 0.70% |
| BB BIOTECH AG | 117,991 | $12,288,000 | 0.63% |